Here are relevant reports on : drug-discovery-market
-
Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030
The global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) & Region - Global Forecast to 2029
The global proteomics market, valued at US$32.98 billion in 2023, stood at US$33.64 billion in 2024 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2029, culminating in a forecasted valuation of US$60.36 billion by the end of the period. The major factors driving growth in the proteomics market are the growing demand for personalized medicines for clinical practices, rising applications in drug discovery and development, growing government & private funding, clinical trial and translational research expansion, biologics and biosimilars development, increasing focus on monoclonal antibodies and therapeutic proteins, and improved techniques in protein quantification.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Digital Pathology Market by Product (Scanner, Software, Storage System), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma & Biotech, Academia, Hospitals) - Global Forecast to 2030
Global digital pathology market valued at $1.30B in 2024, reached $1.46B in 2025, and is projected to grow at a robust 13.5% CAGR, hitting $2.75B by 2030. The key driver of this growth is the mounting need for telepathology to enable pathologists to remotely view slides and interact live over distances. The other factor is integrating artificial intelligence (AI) in digital pathology systems, boosting diagnostics through automated image analysis and predictive analytics.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Lab Automation Market by Product (Robotic Arm, Microplate Reader, Workstation, LIMS, ELN), Application (ADME, Drug Discovery, Diagnostic, Genomic, Proteomic, High Throughput), End User (Pharma, Diagnolab, Forensic, Environmental) - Global Forecast to 2030
The global lab automation market, valued at US$5.97 billion in 2024, stood at US$6.36 billion in 2025 and is projected to advance at a resilient CAGR of 7.2% from 2025 to 2030, culminating in a forecasted valuation of US$9.01 billion by the end of the period. The primary driver of this growth is the increasing demand for high-throughput screening, which enables laboratories to efficiently process large volumes of samples in drug discovery and diagnostics.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029
The global synthetic biology market, valued at US$11.97 billion in 2023, stood at US$12.33 billion in 2024 and is projected to advance at a resilient CAGR of 20.6% from 2024 to 2029, culminating in a forecasted valuation of US$31.52 billion by the end of the period. Some of the prominent factors driving the growth of the market include the rising demand for bio-based products, increased funding in R&D, and collaborations.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
The global pipette calibrators market, valued at US$255 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$391 million by the end of the period. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Cloud Discovery Market by Solution (Application Discovery and Infrastructure Discovery), Service (Professional Services and Managed Services), Organization Size (Large Enterprises and SMES), Vertical, and Region - Global Forecast to 2023
The cloud discovery market is expected to grow from USD 730.8 Million in 2018 to USD 1,564.1 Million by 2023, at a Compound Annual Growth Rate (CAGR) of 16.4% during the forecast period. The demand for cloud discovery solution and services is expected to be driven by several factors, such as applications running in the dynamic Information Technology (IT) environment, growing adoption of multi-cloud environment, and increasing need to efficiently manage the security of IT infrastructure. Major vendors providing cloud discovery solutions and services are AlienVault (US), ASG Technologies (US), BMC Software (US), Certero (UK), CipherCloud (US), Cisco Systems (US), Connectwise (US), iQuate (Ireland), Kmicro (US), ManageEngine (US), McAfee (US), Movere (US), Nephos Technologies (UK), NetSkope (US), Nuvalo (US), Perpetuuiti (Singapore), Puppet (US), Qualys (US), ScienceLogic (US), ServiceNow (US), vArmour (US), Virima Technologies (US), WhiteHat Security (US), Ziften (US), and Zscaler (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029
The global AI in drug discovery market, valued at US$1.39 billion in 2023, stood at US$1.86 billion in 2024 and is projected to advance at a resilient CAGR of 29.9% from 2025 to 2029, culminating in a forecasted valuation of US$6.89 billion by the end of the period. The growth of this market is primarily driven by the growing number of cross-industry collaborations and partnerships, the need to control drug discovery & development costs and reduce the overall time taken in this process, and the increasing focus on oncology indication.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Therapeutic Drug Monitoring Market by Product (Equipments,Consumables), Technology (Immunoassays), Drug Class (Anti–Epileptic Drugs,Anti–Arrhythmic Drugs), Therapeutic Area (Oncology, Cardiology), Specimen (Blood), End user - Global Forecast to 2029
The global therapeutic drug monitoring market, valued at US$2.14 billion in 2023, stood at US$2.30 billion in 2024 and is projected to advance at a resilient CAGR of 8.4% from 2024 to 2029, culminating in a forecasted valuation of US$3.44 billion by the end of the period. This growth is brought on by a number of causes, such as the rise in chronic diseases like cancer, heart disease, epilepsy, and autoimmune conditions.
- Published: December 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
